"Meet & Greet Lunch" with TRI commercial groups

Registrations are closed

Unfortunately the TRI Meet and Greet Lunch has sold out. Make sure you put your name on the waitlist or email: events@tri.edu.au so that we can let you know if there are any cancellations.

"Meet & Greet Lunch" with TRI commercial groups

Have lunch on us and find out about opportunities to work with the commercial groups & biotechs based at TRI.

By Translational Research Institute (TRI)

Date and time

Tue, 31 May 2022 12:00 PM - 1:30 PM AEST

Location

Translational Research Institute

37 Kent Street Woolloongabba, QLD 4102 Australia

About this event

The TRI Research Translation Committee invites TRI-based researchers along with Metro South Clinicians to meet with some of the commercial biotech, medtech and investment groups based at TRI as well as Life Sciences Queensland.

Over lunch in the Atrium, you’ll have the chance to talk to more than 10 groups, and ask them about the products or services and potential opportunities for collaboration. Groups attending include: Brandon Capital, EMVision, Microba, MTPConnect, ThermoFisher Scientific, Ocugene, Oroborus, Vale Life Sciences, Vaxxas, Microbio, TRI Clinical Trials and Therapeutic Innovation Australia.

Numbers are strictly limited so register for your ticket today.

Date: Tuesday 31 May

Time: 12:00-1:30pm

Venue: TRI Atrium, lunch provided

Cost: Free

RVSP: Book your ticket by Friday 27 May

Organised by

The Translational Research Institute (TRI) is a leading Australian medical research, development and translation facility. It is home to a broad range of cutting-edge research into cancer, chronic diseases, mental health conditions, immunology, genetics and more. TRI’s priority is partnering scientific development with clinicians and the MedTech sector to ensure new discoveries progress quickly and improve patient outcomes and commercial return. To this end, TRI is at the interface of science, medicine and industry. Our vision is Exceptional Science, Healthier Lives.

Situated on the Princess Alexandra Hospital precinct, TRI is a joint venture between Queensland Health, The University of Queensland, the Queensland University of Technology and Mater Research.

TRI houses more than 1000 leading researchers, support staff and students and has a community of bio-tech and med-tech start-up companies as well as industry bodies located on its campus. The Institute has two clinical trial facilities, one based at the PA Hospital and the other at the Centre for Children’s Health Research next to the Children’s Hospital.

GET INVOLVED

Sales Ended